Since the onset of the COVID-19 pandemic in 2019 it has become clear that there are sex differences in disease susceptibility and progression. Males are more susceptible to severe COVID-19 diseases and post-infectious or post-vaccine myocarditis, and females suffer from a higher risk for long COVID syndrome. Diseases unique to women, such as Polycystic ovary Syndrome, increase the risk for COVID-19 infection. COVID-19 during pregnancy is strongly associated with preeclampsia and poor outcomes.
We welcome submissions of original articles and reviews on preclinical and clinical research in which findings of new sex differences in COVID-19 are reported. We are particularly interested in studies in which potential mechanisms are tested.
Guest Editor: Licy L Yanes Cardozo
Submission deadline: December 1, 2022
Submit your manuscript here.